78. 下垂体前葉機能低下症 Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 34 / 薬物数 : 44 - (DrugBank : 11) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 19

薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Acipimox
   University of Aarhus
      2016   -   NCT02782208   Denmark
      2012   -   NCT01209416   Denmark
Anastrozole
   Nemours Children's Clinic
      2001   Phase 2/Phase 3   NCT00133354   United States
      -   -   EUCTR2012-001183-30-Outside-EU/EEA   United States
Arimidex
   Nemours Children's Clinic
      2001   Phase 2/Phase 3   NCT00133354   United States
      -   -   EUCTR2012-001183-30-Outside-EU/EEA   United States
Byetta
   Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
      2021   Phase 2   EUCTR2020-004115-27-ES   Spain
Corticotropin
   Max-Planck-Institute of Psychiatry
      2008   -   NCT00666068   Germany
CRH administration
   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      2021   Phase 4   NCT04902235   Spain
Exenatide
   Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
      2021   Phase 2   EUCTR2020-004115-27-ES   Spain
Genotropin 12MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin 5.3MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick
   Dr. Chris Thompson
      2006   Phase 4   EUCTR2005-005613-38-IE   Ireland
Genotropin miniquick 0.2MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.4MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.6MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.8MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 1.0MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 1.2MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
GH pause
   University of Aarhus
      2016   -   NCT02782208   Denmark
GH substitution
   University of Aarhus
      2016   -   NCT02782208   Denmark
Ghrelin
   University of Aarhus
      2012   -   NCT01209416   Denmark
GLP1-RA (exenatide) administration
   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      2021   Phase 4   NCT04897802   Spain
Growth hormone
   Center for Neurological Studies
      2019   Phase 2   NCT04121780   United States
   Federico II University
      1996   -   NCT00462475   Italy
   Nemours Children's Clinic
      2001   Phase 2/Phase 3   NCT00133354   United States
   Stanford University
      2009   Phase 3   NCT01007071   United States
Human acylated ghrelin
   University of Aarhus
      2005   -   NCT00139945   Denmark
Hydrocortisone
   Amar Agha
      2008   Phase 4   EUCTR2007-005018-37-IE   Ireland
   University Hospital Inselspital, Berne
      2015   -   NCT02360046   Switzerland
Hydrocortisone takeda, tabletter
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark
Hydrocortone
   Amar Agha
      2008   Phase 4   EUCTR2007-005018-37-IE   Ireland
   Bradford Teaching Hospitals NHS Foundation Trust
      2004   Phase 4   EUCTR2004-002056-34-GB   United Kingdom
Hydrokortison glostrup 5 MG
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark
Intravenous infusion OF diclofenac sodium
   Azienda Ospedaliera Città della Salute e della Scienza di Torino
      2021   Phase 4   NCT05188131   Italy
Levothyroxine
   Christie Hospital NHS Trust
      2005   -   EUCTR2004-005184-15-GB   United Kingdom
   Rigshospitalet, Denmark
      2012   -   NCT01574859   Denmark
Melatonin
   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      2022   -   NCT05319301   Spain
Nutropin AQ
   Children's Hospital Los Angeles
      2004   Phase 4   NCT00140413   United States
Oestrogen
   University of Aarhus
      2001   -   NCT00572390   Denmark
Plenadren 20 MG modified-release tablets
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark
Plenadren 5 MG modified-release tablets
   Rigshospitalet, Copenhagen University Hospital
      2014   Phase 4   EUCTR2014-002039-32-DK   Denmark
Routine transdermal oestrogen patch
   University College, London
      2016   -   NCT02871986   United Kingdom
Somatropin
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
   Eli Lilly and Company
      2002   -   NCT01088399   -
      1999   Phase 4   NCT00490191   France;Germany;Italy;Puerto Rico;United Kingdom;United States
   Novo Nordisk A/S
      2002   -   NCT01009905   United States
Synacthen
   Cardiff University
      2008   Phase 4   NCT00851942   United Kingdom
      2008   Phase 4   EUCTR2007-000056-14-GB   United Kingdom
Testogel
   Dr. Chris Thompson
      2006   Phase 4   EUCTR2005-005613-38-IE   Ireland
Testosterone plus somatropin
   University of Pennsylvania
      2004   Phase 2   NCT00080483   United States
Tetracosactrin
   Cardiff University
      2008   Phase 4   NCT00851942   United Kingdom
Theraderm
   Massachusetts General Hospital
      2001   -   NCT00027430   United States
Thyroxin, triiodothyronine
   University Hospital Freiburg
      2004   Phase 4   NCT00360074   Germany
Transdermal testosterone GEL
   Charles Drew University of Medicine and Science
      2003   Phase 4   NCT00144391   United States
Trisequens
   Dr. Chris Thompson
      2006   Phase 4   EUCTR2005-005613-38-IE   Ireland
ZD1033
   Nemours Children's Clinic
      -   -   EUCTR2012-001183-30-Outside-EU/EEA   United States